Articles tagged with Pharmaceutical Industry
The pharmaceutical industry invests heavily in medical information, which can impact clinical practice and patient outcomes. However, this information is often kept secret, duplicated, and biased towards commercial interests, undermining public health needs.
According to Professor Rugman's research, only a handful of multinational companies, such as Nestlé and Unilever, can be considered 'global'. The majority focus on sales within their home region, with many struggling to maintain profitable foreign operations. This trend towards 'de-globalisation' is driven by persistently poor global p...
A study of internal tobacco industry documents reveals that companies profited from both tobacco and nicotine replacement therapies, undermining efforts to combat smoking addiction. Researchers argue that such financial conflicts of interest should be made public to ensure greater corporate responsibility.
A multidisciplinary team at Abbott Laboratories developed an innovative process to produce the protease inhibitor ritonavir, leading to the discovery of next-generation protease inhibitor lopinavir. This breakthrough has improved HIV/AIDS treatment outcomes and saved thousands of lives in the US.
A management science study finds public research has a significant impact on industrial R&D, with the pharmaceutical industry being a major beneficiary. The study reveals that public research contributes to both innovation and project completion, with materials science and computer science fields having the most widespread impact.
The American College of Physicians has updated its guidelines to ensure physicians maintain independence in patient care. The new advice urges individual physicians to avoid industry relationships that may compromise objectivity.
A study of 300 airline staff found that current smokers took almost three times as much sick leave as non-smokers, while ex-smokers had lower rates of absenteeism. Ex-smokers were also 5% more productive than current smokers, with productivity increasing over time.
Researchers at the University of Illinois Chicago have developed a fluorous chemistry-based method to convert alcohols into aldehydes and ketones, retaining the convenience of the Swern reaction. The new reagents eliminate the byproduct dimethyl sulfide, producing an odorless and easily recyclable alternative.
The book examines key issues in dietary supplements, including shelf life testing, regulatory implications, and standardizing botanical extracts. Experts address the need for critical pre-purchase research to protect consumers from potentially dangerous or ineffective products.
The Colloquium on Perspectives of Bioengineering at UCSD will bring together bioengineering leaders to discuss future advancements. The event, sponsored by the Jacobs School of Engineering, is a free public lecture open to all.
The Keck Graduate Institute will host a workshop on post-baccalaureate alternatives for science and math majors, exploring new M.S. professional degrees in the biosciences. The program aims to equip students with promising career opportunities in pharmaceuticals, biotechnology, and medical industries.
The AAPS is co-sponsoring the FDA Science Forum, bringing together experts in bioengineering, diagnostics, and regulatory science to discuss the impact of biotechnology on product development and regulation. The forum will cover topics such as gene therapy, cell and tissue engineering, and vaccine development.
The ACS Industry Pavilion features presentations and workshops from renowned scientists, including Nobel laureate Julius Axelrod and pharmaceutical executives. The pavilion also addresses the future of the chemical industry through a panel discussion on trends and their impact on careers.